Clonazepam
Product Images NDC 64725-3004

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 64725-3004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 3004)

Label Image (64725 3004)
This is a description of Clonazepam, a prescription medication indicated for the treatment of seizures, panic disorder, and anxiety. The description includes the dosage form, strength (1mg tablets), and the number of tablets per container (15CTCD). It emphasizes that it is a prescription medication (RX ONLY) and includes the drug's National Drug Code (0228-3004-11), lot number, expiration date, and manufacturer information (MFR: ACTAVIS). The medication has been repackaged by T.Y.A. Pharmaceuticals with their contact information provided. The description advises referring to the package insert for dosing information.*
FDA Label Image

Label Image (64725 3005)

Label Image (64725 3005)
This is a description of a medication called Clonazepam. It comes in a tablet form with a strength of 2mg and is classified as a controlled substance (CIV). This particular package comes with 30 tablets and has a National Drug Code (NDC) identifier of 0228-3005-11. The batch or lot number is "00" and the expiration date is not provided. The manufacturer is Actavis and the packaging was done by TY.A. Pharmaceuticals in Tallahassee, Florida. The recommended dosage is available in the package insert.*
FDA Label Image

Cdfd5711-figure-01 (Cdfd5711 Figure 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.